You are viewing: China Diagnostic Contract Manufacturing Market analysis

The China Diagnostic Contract Manufacturing Market was valued at $5366.1 Million in 2023 and projected to reach to $10785 Million by 2028, representing a compound annual growth rate of 15.0%. China's diagnostic contract manufacturing market is poised for sustained expansion, growing from $5,366.1 million in 2023 to $10,785.0 million by 2028.

China Diagnostic Contract Manufacturing Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Diagnostic Contract Manufacturing Market Trends and Insights

  • China's market expansion is driven by increasing demand for in vitro diagnostic (IVD) devices, rising healthcare expenditure, and the country's position as a global manufacturing hub for diagnostic components.
  • The rapid industrialization of China's healthcare sector and government initiatives supporting domestic diagnostic innovation are accelerating contract manufacturing adoption across the region. China's diagnostic contract manufacturing landscape is characterized by growing investments in automation, quality assurance infrastructure, and regulatory compliance capabilities.
  • China continues to attract multinational diagnostic manufacturers seeking cost-effective production solutions while maintaining stringent quality standards.
  • The forecast period through 2028 reflects China's strengthening role in the Asia Pacific diagnostic contract manufacturing ecosystem, supported by technological advancement and expanding clinical laboratory networks throughout the country..

Key Market Statistics

  • CAGR (2023-2028) 15.0% CAGR
  • Market Size, 2023 ~USD 5366.1 Million
  • Forecast, 2028 ~USD 10785 Million
  • Country China

China Diagnostic Contract Manufacturing Market Overview

Rapid Market Expansion :

China's diagnostic contract manufacturing market is experiencing exceptional growth at 15% CAGR, significantly outpacing the global rate of 11.5%, driven by robust domestic demand and manufacturing capabilities.

IVD Device Demand Surge :

Increasing adoption of in vitro diagnostic devices across Chinese healthcare facilities, coupled with government initiatives to expand diagnostic testing infrastructure, is fueling substantial market growth.

Healthcare Investment Acceleration :

Rising healthcare expenditure in China, supported by government healthcare reforms and improved insurance coverage, is creating unprecedented opportunities for diagnostic contract manufacturers.

Global Manufacturing Hub Status :

China's established position as a global manufacturing center, combined with cost advantages and technical expertise, positions it as a critical hub for diagnostic device contract manufacturing.

China Diagnostic Contract Manufacturing Market Dynamics

  • This robust 15% CAGR reflects China's strategic importance in global diagnostic supply chains and the country's commitment to advancing healthcare infrastructure.
  • The market benefits from increasing domestic demand for IVD devices, government support for medical device manufacturing, and China's competitive manufacturing ecosystem. Looking ahead, China's market will be shaped by technological advancement in diagnostic testing, regulatory harmonization efforts, and rising healthcare accessibility in tier-2 and tier-3 cities.
  • Contract manufacturers are increasingly investing in automation, quality assurance capabilities, and regulatory compliance to meet international standards.
  • Strategic partnerships between Chinese manufacturers and global diagnostic companies will continue to drive market growth and innovation..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • China's diagnostic contract manufacturing market is projected to double from $5,366.1M (2023) to $10,785.0M (2028) at a 15.0% CAGR.
    • China's position as a global manufacturing hub and rising healthcare investments are primary growth catalysts for diagnostic contract manufacturing.
    • China is experiencing increased adoption of automation and quality infrastructure to meet international regulatory standards.
    • China's expanding clinical laboratory networks and government support for domestic diagnostics innovation drive sustained market expansion through 2028.

    Diagnostic Contract Manufacturing Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment CARDIOLOGY (Application)
    Forecast Period 2023-2028
    Growth Rate CAGR of 11.5% from 2023 to 2028
    Largest Segment DEVICE DEVELOPMENT AND MANUFACTURING SERVICES (Service)
    Market Size Base Year (Billions) ~USD 26.05 (2023)
    Revenue Forecast (Billions) ~USD 44.9 (2028)
    Segments Covered Device Type, Type, Service, Application

    China Diagnostic Contract Manufacturing Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Device Type

    • Diagnostic Imaging Devices
    • In Vitro Diagnostic Devices
    • Other Devices

    By Type

    • Ct
    • Ivd Consumables
    • Ivd Equipment
    • Mri
    • Other Diagnostic Imaging Devices
    • Ultrasound
    • X-Ray

    By Service

    • Device Development And Manufacturing Services
    • Other Services
    • Packaging And Assembly Services
    • Quality Management Services

    By Application

    • Cardiology
    • Diabetes
    • Gastroenterology
    • Gynecology
    • Infectious Diseases
    • Neurology
    • Oncology
    • Orthopedics
    • Other Applications

    CHINA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028

    Segment20212022202320242025202620272028CAGR (%)
    GASTROENTEROLOGY101.1116.7137.1160.7188.3220.6257.7300.417
    GYNECOLOGY90.5104.6123.2145170.7201.1236.3277.617.6
    OTHER APPLICATIONS217.8243.6277.6316.2360.1410.5466.8530.513.8
    TOTAL409.4464.9537.9621.9719.1832.2960.81108.515.6

    CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028

    Segment20212022202320242025202620272028CAGR (%)
    CARDIOLOGY233.1267.1311.9363.9424.6495.9577.7672.416.6
    DIABETES370.8412466.5527.6596.9675.9763.4861.613.1
    INFECTIOUS DISEASES951.71079.61247.51439.51660.51916.62205.72535.715.2
    ONCOLOGY314.2358415.6482559.1649.1751.7869.915.9
    OTHER APPLICATIONS654.1724.5817.8922.31040.11174.31322.31487.812.7
    TOTAL2523.92841.23259.33735.34281.24911.85620.86427.414.5

    Target Audience

    • Diagnostic Device Manufacturers : Need market data to evaluate China as a contract manufacturing destination, assess capacity availability, and identify strategic partners for outsourcing diagnostic device production.
    • Contract Manufacturing Organizations (CMOs) : Require market sizing and growth forecasts to justify capacity investments, plan facility expansion, and develop targeted business development strategies in China's high-growth market.
    • Healthcare Investment Firms : Seek comprehensive market analysis to evaluate investment opportunities in Chinese diagnostic manufacturing companies, assess portfolio company growth potential, and identify acquisition targets.
    • Medical Device Suppliers & Vendors : Need China-specific market intelligence to understand demand for manufacturing inputs, identify key customer segments, and develop targeted sales strategies for diagnostic manufacturing solutions.
    • Healthcare Consultants & Analysts : Require verified market data and forecasts to support client advisory work, competitive benchmarking, and strategic recommendations for diagnostic manufacturing operations in China.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation ($5.4B in 2023) and verified 15% CAGR projections through 2028 to support investment decisions and strategic planning in China's high-growth diagnostic manufacturing sector.
    • Competitive Positioning Intelligence : Understand China's market dynamics relative to global trends (11.5% CAGR) to identify competitive advantages, market gaps, and opportunities for differentiation in diagnostic contract manufacturing.
    • Demand Driver Analysis : Access detailed insights into China-specific growth catalysts including IVD device demand, healthcare expenditure trends, and government initiatives to inform market entry and expansion strategies.
    • Investment & Partnership Opportunities : Identify high-potential segments and regional opportunities within China's diagnostic manufacturing ecosystem to guide M&A activities, joint ventures, and capacity expansion decisions.
    • Regulatory & Operational Insights : Gain China-specific intelligence on manufacturing capabilities, quality standards, and regulatory requirements essential for establishing or scaling diagnostic contract manufacturing operations.

    Frequently asked questions

    What is the current size of China's diagnostic contract manufacturing market?

    China's diagnostic contract manufacturing market was valued at $5,366.1 million in 2023 and is expected to reach $10,785.0 million by 2028.

    What is the projected growth rate for China's diagnostic contract manufacturing market?

    China's diagnostic contract manufacturing market is projected to grow at a compound annual growth rate (CAGR) of 15.0% from 2023 to 2028.

    What factors are driving growth in China's diagnostic contract manufacturing sector?

    Key growth drivers in China include rising healthcare expenditure, increasing demand for IVD devices, China's role as a global manufacturing hub, government innovation initiatives, and expanding clinical laboratory networks.

    Why is China becoming a preferred location for diagnostic contract manufacturing?

    China attracts diagnostic manufacturers through cost-effective production capabilities, advanced automation infrastructure, improving quality assurance systems, regulatory compliance expertise, and access to skilled manufacturing talent.

    How is China's diagnostic contract manufacturing market expected to evolve by 2028?

    By 2028, China's market is expected to nearly double in value, with continued investments in automation, quality infrastructure, and regulatory capabilities supporting its role as a key Asia Pacific diagnostic manufacturing center.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product/service launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the diagnostic contract manufacturing market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the diagnostic contract manufacturing market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the diagnostic contract manufacturing market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as clinical laboratories, hospitals, and academic & research institutes) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, and Rest of the World. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Diagnostic Contract Manufacturing Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various sleep apnea were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value diagnostic contract manufacturing market was also split into various segments and subsegments at the regional and country level based on the following:

    • Product mapping of various manufacturers for each type of diagnostic contract manufacturing market at the regional and country-level 
    • Relative adoption pattern of each diagnostic contract manufacturing market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Diagnostic contract manufacturing Market Size: Botton Up Approach

    Diagnostic Contract Manufacturing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Diagnostic contract manufacturing market Size: Top-Down Approach

    Diagnostic Contract Manufacturing Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Diagnostic contract manufacturing industry.

    Market Definition

    Diagnostic contract manufacturing is a process wherein a manufacturing company makes diagnostic devices or the components of devices that can be sold later by other companies. Diagnostic device contract manufacturers specialize in a certain process or task and offer expertise due to their frequent practice of manufacturing.

    Key Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global diagnostic contract manufacturing market by device type, service, application, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, challenges, and trends)
    • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the overall diagnostic contract manufacturing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to four regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    Additional country-level analysis of the Diagnostic contract manufacturing market

    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Diagnostic contract manufacturing Market

    Get the Full Diagnostic Contract Manufacturing Market Report

    Full forecast, segment splits, and company analysis for all Diagnostic Contract Manufacturing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status